Patent: 10,000,554
✉ Email this page to a colleague
Summary for Patent: 10,000,554
Title: | Modified laminin containing collagen binding molecule and use thereof |
Abstract: | A modified laminin characterized in that a laminin or a heterotrimeric laminin fragment has a collagen binding molecule conjugated to at least one site selected from the .alpha. chain N-terminus, the .beta. chain N-terminus and the .gamma. chain N-terminus, and an extracellular-matrix material comprising the modified laminin, and collagen and/or gelatin serve as an alternative to Matrigel and are useful as an extracellular-matrix material for the formation of a safe three-dimensional tissue structure for regenerative medicine in humans. |
Inventor(s): | Sekiguchi; Kiyotoshi (Osaka, JP), Li; Shaoliang (Osaka, JP), Sato; Ryoko (Osaka, JP) |
Assignee: | OSAKA UNIVERSITY (Osaka, JP) |
Application Number: | 14/758,061 |
Patent Claims: | see list of patent claims |
Details for Patent 10,000,554
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2032-12-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |